Skip to main content
OpenTrials
Completed

NCT Number: NCT01677481

Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial

The study compares radiation exposure parameters between coronary angiography procedures performed by left wrist, right wrist or groin (femoral) procedure access site

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Exposure to Ionizing Radiation

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

V.S. General Hospital

Ahmedabad, Gujarat, 380006, India

About this study

Patients referred for coronary angiography will be randomized to either left radial, right radial or femoral arterial access sites, and the coronary angiogram will be performed in a standard fashion, including left ventriculography. Radiation exposure parameters including Air Kerma, Dose-area product, Fluoroscopy time and Operator radiation exposure will be recorded. Operator experience as well as demographic data will be recorded.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients undergoing diagnostic coronary angiography

Exclusion criteria

  • non-availability of one or more of the three access sites History of coronary artery bypass graft surgery Need for percutaneous coronary intervention.

Treatment and study plan

Primary outcomes

  1. Air Kerma

    Time frame: 1 day

    The investigators will measure Air Kerma (cumulative) at the end of the procedure of coronary angiography.

Other outcomes

  1. Operator radiation exposure

    Time frame: 1 day

    operator radiation exposure will be measured by a personal dosimeter worn by the operator outside the lead apron on the vest pocket.

Sponsors and collaborators

Lead sponsor

Total Cardiovascular Solutions

Other

Registry information

Official study title

Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial.

Acronym: REVERE

Important dates

Study start
2011
Primary completion
2014
Study completion
2014
First posted
Sep 3, 2012
Registry last updated
Mar 15, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.